| Christiana Moustakas O'hara, MS CCC-SLP | |
|
1450 Chapel St, New Haven, CT 06511-4405 | |
| (508) 735-6270 | |
| Not Available |
| Full Name | Christiana Moustakas O'hara |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1450 Chapel St, New Haven, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326652108 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 003633 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christiana Moustakas O'hara, MS CCC-SLP 15 Belle Vale St, Monroe, CT 06468-1534 Ph: (508) 735-6270 | Christiana Moustakas O'hara, MS CCC-SLP 1450 Chapel St, New Haven, CT 06511-4405 Ph: (508) 735-6270 |
News Archive
A diverse team of scientists from UCLA's Jonsson Comprehensive Cancer Center has developed an experimental treatment that eradicates an acute type of leukemia in mice without any detectable toxic side effects.
Children and youth who experience hunger appear more likely to have health problems, and repeated episodes of hunger may be particularly toxic, according to a report in the August issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
Researchers report that 28 cases of ciguatera fish poisoning occurred in New York City during 2010–2011, a greater number than were reported during the preceding 10-year period.
Plexxikon Inc. announces that enrollment has been initiated and the first patient has been dosed in a pivotal Phase 3 trial of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly targeted drug that is designed to inhibit the BRAF cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors. The randomized, controlled, Phase 3 "BRAF Inhibitor in Melanoma" (BRIM3) trial in previously untreated patients is part of the planned registration program for PLX4032.
› Verified 7 days ago
Ruchi Chandrakant Rana, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-512-8951 | |
Rachel Wiberg, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 335 Orange St Apt 501, New Haven, CT 06511 Phone: 203-470-3249 | |
Richard Wurtzel, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 York St Apt 14d, New Haven, CT 06511 Phone: 203-605-7229 | |
Lynn M Acton, MS Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave, Yale Physicians Building-4th Fl, New Haven, CT 06519 Phone: 203-785-2593 Fax: 203-785-5936 | |
Aleeza Sarah Zeiger, Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 122 Hubinger St Fl 3, New Haven, CT 06511 Phone: 203-232-3069 | |
John Patrick Gerrity Jr., MA, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave Fl 4, New Haven, CT 06519 Phone: 203-785-5430 | |
Eva Montas, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 118 Clinton Ave, New Haven, CT 06513 Phone: 860-840-0861 |